MedPath
FDA Approval

Cosyntropin

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
November 3, 2023
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Tetracosactide(0.25 mg in 1 mL)

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Medical Purchasing Solutions, LLC

Medical Purchasing Solutions, LLC

601458529

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Cosyntropin

Product Details

NDC Product Code
71872-7313
Application Number
ANDA202147
Marketing Category
ANDA (C73584)
Route of Administration
INTRAVENOUS
Effective Date
November 3, 2023
MANNITOLInactive
Code: 3OWL53L36AClass: IACTQuantity: 10 mg in 1 mL
Code: 72YY86EA29Class: ACTIBQuantity: 0.25 mg in 1 mL
© Copyright 2025. All Rights Reserved by MedPath